Opexa Presents Tovaxin(tm) Research at Federation of Clinical ...
Business Wire (press release) - San Francisco,CA,USA
"These findings mark an important development for Tovaxin, which is a patient-specific autologous T-cell vaccine, because it helps us qualify subjects for ...
See all stories on this topic